ELOX Earnings Eloxx Pharmaceuticals, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–15 of 15
| Q1 2026 | 2026-03-31 | -0.08 | 2026-05-05 | 10-Q |
| FY 2025 | 2025-12-31 | -0.49 | 2026-03-17 | 10-K |
| Q1 2026 | 2025-03-31 | -0.45 | 2026-05-05 | 10-Q |
| FY 2025 | 2024-12-31 | -0.84 | 2026-03-17 | 10-K |
| FY 2025 | 2023-12-31 | -6.63 | 2026-03-17 | 10-K |
| Q3 2023 | 2023-09-30 | -5.96 | 2023-11-13 | 10-Q |
| Q2 2023 | 2023-06-30 | -4.83 | 2023-08-11 | 10-Q |
| Q1 2023 | 2023-03-31 | -2.88 | 2023-05-12 | 10-Q |
| FY 2022 | 2022-12-31 | -16.65 | 2023-03-31 | 10-K |
| Q3 2023 | 2022-09-30 | -13.73 | 2023-11-13 | 10-Q |
| Q2 2023 | 2022-06-30 | -10.27 | 2023-08-11 | 10-Q |
| Q1 2023 | 2022-03-31 | -5.36 | 2023-05-12 | 10-Q |
| FY 2022 | 2021-12-31 | -38.15 | 2023-03-31 | 10-K |
| Q3 2022 | 2021-09-30 | -0.85 | 2022-11-10 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.84 | 2022-08-12 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.